会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 33. 发明申请
    • Method to ameliorate osteolysis and metastasis
    • 改善骨质溶解和转移的方法
    • US20050244414A1
    • 2005-11-03
    • US11109470
    • 2005-04-18
    • Gregory MundyYoshiyuki YonedaTheresa Guise
    • Gregory MundyYoshiyuki YonedaTheresa Guise
    • C12N15/09A61K9/08A61K31/66A61K31/675A61K38/00A61K39/395A61K45/06A61P35/00A61P43/00C07K16/22C07K16/24C07K16/26C12P21/08A61K31/663
    • C07K16/244A61K38/00A61K45/06C07K16/22C07K16/241C07K16/26
    • A therapeutically effective amount of an antibody for a compound selected from the group consisting of PTHrp, TGFα, IL-1α, IL-1β, IL-6, Lymphotoxin, TNF, PGE; 1,25 dihydroxy vitamin D3 and an antigenic fragment thereof used in the treatment of cancer metastasis to bone and cancer cell growth in bone as well as osteolysis and symptomatic sequelae thereof. An antibody immunoreactive with parathyroid hormone-related protein (PTHrp) is particularly preferred. Antibodies with human characteristics are included in the invention for application of the invention method to human subjects. Also, the antibody can be administered in an injectable is formulation in combination with a therapeutically effective amount of a bisphosphonate or pyrophosphate having the general structure formula wherein X is a linking moiety allowing for the interconnection of the phosphonate groups, and pharmaceutically acceptable salts, hydrates and partial hydrates thereof. The antibody and bisphosphonate act synergistically in the treatment of cancer metastases to bone and symptomatic sequelae thereof and particularly as regards bone resorption.
    • 治疗有效量的选自PTHrp,TGFα,IL-1α,IL-1β,IL-6,淋巴毒素,TNF,PGE的化合物的抗体; 1,25二羟基维生素D 3及其抗原性片段用于治疗癌症转移至骨骼和骨细胞中的癌细胞,以及骨溶解及其症状后遗症。 与甲状旁腺激素相关蛋白(PTHrp)免疫反应的抗体是特别优选的。 具有人类特征的抗体包括在本发明中,用于将本发明方法应用于人类受试者。 此外,抗体可以以可注射的制剂与治疗有效量的具有以下通式结构式的二膦酸盐或焦磷酸盐组合施用:其中X是允许膦酸酯基团互连的连接部分,以及药学上可接受的盐,水合物 和其部分水合物。 抗体和双膦酸盐协同作用于治疗癌症转移至骨骼及其有症状的后遗症,特别是关于骨吸收。